Abide Therapeutics clinical trials
Acquired by H. Lundbeck A/S
The registry lists 6 studies whose lead sponsor is Abide Therapeutics. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Apr 8, 2020.
Registry sponsor names on this page
- Abide Therapeutics6 studies
Something wrong with this grouping? Tell us on the H. Lundbeck A/S page.
Studies
Recruiting first, then most recently updated. Showing 6 of 6. All H. Lundbeck A/S studies →
- Study of ABX-1431 in Adult Patients With Tourette Syndrome or Chronic Motor Tic DisorderCompletedNCT03625453Phase 2
Sponsor listed in the registry: Abide Therapeutics · Abide Therapeutics — acquired company within the H. Lundbeck A/S group
- Titration Study of ABX-1431CompletedNCT03447756Phase 1
Sponsor listed in the registry: Abide Therapeutics · Abide Therapeutics — acquired company within the H. Lundbeck A/S group
- Central Pain Study for ABX-1431CompletedNCT03138421Phase 1
Sponsor listed in the registry: Abide Therapeutics · Abide Therapeutics — acquired company within the H. Lundbeck A/S group
- An fMRI Study in Healthy Volunteers to Investigate the Effects of ABX-1431 on Experimental Hyperalgesia and Its Neural CorrelatesCompletedNCT02929264Phase 1
Sponsor listed in the registry: Abide Therapeutics · Abide Therapeutics — acquired company within the H. Lundbeck A/S group
- A Study to Evaluate the Effects of ABX-1431 on Patients With Tourette SyndromeCompletedNCT03058562Phase 1
Sponsor listed in the registry: Abide Therapeutics · Abide Therapeutics — acquired company within the H. Lundbeck A/S group
- A Study to Evaluate the Effects of ABX-1431 on Patients With Functional DyspepsiaTerminatedNCT02875678Phase 1
Sponsor listed in the registry: Abide Therapeutics · Abide Therapeutics — acquired company within the H. Lundbeck A/S group